Therapeutic Drug Monitoring in IBD: A Testing Guide

Therapeutic Drug Monitoring in IBD

Therapeutic drug monitoring (TDM) assays can help make personalized medicine possible for IBD patients, as they can predict and define loss of response (LOR) to commonly used therapeutics on the market including adalimumab and infliximab. Therapeutic drug monitoring in IBD offers a significant advantage to the patient in terms of saving money as well as finding the right dose or agent for a better clinical outcome.